WebSep 12, 2024 · Pherecydes Pharma (FR0011651694 - ALPHE) (Paris:ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today... WebApr 14, 2024 · A Nantes, Aviti absorbe Data 7. Loire-Atlantique 14/04/2024. Lire l'article. Edito de La Lettre API hebdo ... Pherecydes Pharma 04/01/2024 Voir tout. Ouest-France Communication Banques. La stratégie de LCL pour s’engager dans la finance durable. Publi-rédactionnel 20/07/2024 Mentions légales; Données personnelles ...
Pherecydes Pharma Announces Its 2024 Annual Financial Results and …
WebApr 7, 2024 · Pherecydes Pharma Société anonyme is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages. The €19m market-cap company posted a loss in its … WebDetails. Pherecydes Pharma develops phage-based therapeutic solutions for the treatment of bacterial infections. It focuses on va. Drug Discovery. Nantes, France. 27 As of 2024. 000.00. 000000&0 000.00. marvell avastar wireless driver download
Pherecydes Pharma Selected for the French Tech Health20 …
WebInvista em Pherecydes Pharma, Euronext Paris: ALPHE Ação - Veja o preçário ALPHE em tempo real. Comissões grátis online em investimentos em Pherecydes Pharma: compra ou venda Pherecydes Pharma Ação sem custos de comissão com a Trading 212. WebDec 16, 2024 · The financing will be used, as well, to set up a 10,000 square feet (approx 1,000M2)pharmaceutical production unit in Nantes. In addition, new research programs will be launched in 2024 and 2024. In addition, new research programs will be launched in 2024 and 2024. ... Pherecydes Pharma’s business model means that revenues from the sale of ... marvell avastar wireless network controller